QUIDELORTHO CORP Income (Loss) from Equity Method Investments
QUIDELORTHO CORP (QDEL) reported Income (Loss) from Equity Method Investments of -$8.10 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-08-07
- QUIDELORTHO CORP income (loss) from equity method investments for the quarter ending 2026-06-28 was -$8.10M, a 910.00% decline year-over-year.
- QUIDELORTHO CORP income (loss) from equity method investments for the quarter ending 2026-03-29 was -$900.00K, a 400.00% decline year-over-year.
- QUIDELORTHO CORP income (loss) from equity method investments for the quarter ending 2025-06-29 was $1.00M, a 42.86% increase year-over-year.
- QUIDELORTHO CORP income (loss) from equity method investments for the quarter ending 2025-03-30 was $300.00K.
- QUIDELORTHO CORP income (loss) from equity method investments for fiscal 2025 was $2.50M, a 257.14% increase from fiscal 2024.
- QUIDELORTHO CORP income (loss) from equity method investments for fiscal 2024 was $700.00K.
- QUIDELORTHO CORP income (loss) from equity method investments for fiscal 2023 was -$3.60M.
- QUIDELORTHO CORP income (loss) from equity method investments for fiscal 2023 was -$5.80M, a 486.67% decline from fiscal 2022.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2026-06-28 | -$8.10M 10-Q · filed 2026-08-07 | -$9.00M 10-Q · filed 2026-08-07 | ||
| 2026-03-29 | -$900.00K 10-Q · filed 2026-05-06 | |||
| 2025-12-28 | $2.50M 10-K · filed 2026-02-19 | |||
| 2025-06-29 | $1.00M 10-Q · filed 2026-08-07 | $1.30M 10-Q · filed 2026-08-07 | $2.00M derived: sum of 3 quarters · filed 2026-08-07 | $2.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-30 | $300.00K 10-Q · filed 2026-05-06 | $1.00M derived: sum of 2 quarters · filed 2026-05-06 | $1.00M derived: sum of 3 quarters · filed 2026-05-06 | $1.70M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-29 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $700.00K derived: sum of 2 quarters · filed 2026-02-19 | $1.40M derived: sum of 3 quarters · filed 2026-02-19 | $700.00K 10-K · filed 2026-02-19 |
| 2024-09-29 | $0.00 10-Q · filed 2024-11-08 | $700.00K derived: sum of 2 quarters · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $700.00K 10-Q · filed 2024-08-01 | $0.00 10-Q · filed 2024-08-01 | ||
| 2023-12-31 | -$2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$3.40M derived: sum of 2 quarters · filed 2026-02-19 | -$3.60M derived: sum of 3 quarters · filed 2026-02-19 | -$3.60M 10-K · filed 2026-02-19 |
| 2023-10-01 | -$1.00M 10-Q · filed 2024-11-08 | -$1.20M derived: sum of 2 quarters · filed 2024-11-08 | -$1.20M 10-Q · filed 2024-11-08 | |
| 2023-07-02 | -$200.00K 10-Q · filed 2024-08-01 | -$200.00K 10-Q · filed 2024-08-01 | ||
| 2023-01-01 | -$5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$5.00M derived: sum of 2 quarters · filed 2025-02-27 | -$5.80M derived: sum of 3 quarters · filed 2025-02-27 | -$5.80M 10-K · filed 2025-02-27 |
| 2022-10-02 | $0.00 10-Q · filed 2023-11-02 | -$800.00K derived: sum of 2 quarters · filed 2023-11-02 | -$800.00K 10-Q · filed 2023-11-02 | |
| 2022-07-03 | -$800.00K 10-Q · filed 2023-08-09 | -$800.00K 10-Q · filed 2023-08-09 | ||
| 2022-01-02 | $300.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | $1.50M derived: sum of 2 quarters · filed 2024-08-01 | $1.50M derived: sum of 3 quarters · filed 2024-08-01 | $1.50M 10-K/A · filed 2024-08-01 |
| 2021-10-03 | $1.20M 10-Q · filed 2022-11-04 | $1.20M derived: sum of 2 quarters · filed 2022-11-04 | $1.20M 10-Q · filed 2022-11-04 | |
| 2021-07-04 | $0.00 10-Q · filed 2022-08-05 | $0.00 10-Q · filed 2022-08-05 | ||
| 2021-01-03 | $0.00 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |